$Flexion Therapeutics(FLXN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-002559 Size: 5 KB 网页链接
$Flexion Therapeutics(FLXN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-002556 Size: 9 KB 网页链接
$Flexion Therapeutics(FLXN)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-21-002004 Size: 11 KB 网页链接
$Flexion Therapeutics(FLXN)$ 8-K Current report, item 5.02 Accession Number: 0001564590-20-054672 Act: 34 Size: 160 KB 网页链接
$Flexion Therapeutics(FLXN)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001564590-20-050593 Act: 33 Size: 425 KB 网页链接
$Flexion Therapeutics(FLXN)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-20-050458 Act: 34 Size: 11 MB 网页链接
$Flexion Therapeutics(FLXN)$ 8-K Current report, items 1.01, 2.02, and 9.01 Accession Number: 0001564590-20-050450 Act: 34 Size: 894 KB 网页链接
$Flexion Therapeutics(FLXN)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-20-002508 Act: 33 Size: 1 KB 网页链接
$Flexion Therapeutics(FLXN)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001564590-20-043269 Act: 33 Size: 777 KB 网页链接